Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Role of heat shock proteins in the cardioprotection of regular moderate alcohol ...
Journal Information
Vol. 146. Issue 7.
Pages 292-300 (April 2016)
Share
Share
Download PDF
More article options
Visits
1
Vol. 146. Issue 7.
Pages 292-300 (April 2016)
Original article
Role of heat shock proteins in the cardioprotection of regular moderate alcohol consumption
Proteínas de choque térmico en la cardioprotección del consumo moderado regular de alcohol
Visits
1
Maria Concepción Guisasola
Unidad de Medicina y Cirugía Experimental, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (6)
Table 1. Demographics of the population studied according to their regular alcohol consumption levels.
Table 2. Concentration of heat shock proteins and heat shock non-protein antibodies in the general population according to regular alcohol consumption.
Table 3. Concentration of heat shock proteins and heat shock non-protein antibodies in the general population segmented by sex according to regular alcohol consumption.
Table 4. Concentration of heat shock proteins and heat shock non-protein antibodies in the general population according to the degree of vascular risk and daily alcohol consumption.
Table 5. Concentration of heat shock proteins and heat shock non-protein antibodies in the general population according to the degree of vascular risk and daily alcohol consumption in men.
Table 6. Concentration of heat shock proteins and heat shock non-protein antibodies in the general population according to the degree of vascular risk and daily alcohol consumption in women.
Show moreShow less
Abstract
Background and objectives

To study whether the cardioprotective effect of regular alcohol consumption can be explained by the heat shock proteins (HSP), given their pathogenic role in atherosclerosis.

Material and methods

Cross-sectional epidemiological study on 452 men and women aged 40–60. Clinical history, epidemiological survey (frequency of average alcohol consumption) and biochemical analysis was performed; Task Force Chart was applied for classification according to the risk of vascular disease. Intracellular HSPA1A, circulating HSPA1A and HSPD1, and anti-Hsp70/anti-Hsp60 antibodies were quantified by ELISA.

Results

Two hundred and thirty-eight (52.7%) were abstemious or drank <20g/d of alcohol; 123 (27.2%) drank 20–40g/d, 66 (14.6%) 40–60g/d and 25 >60g/d (5.5%). Two hundred and thirty-nine had no vascular risk (VR) factor or a risk <5%, 161 had moderate VR (10–20%) and 52 had established atherosclerotic disease. Drinkers of 40–60g/d showed the highest concentrations of intracellular HSPA1A, which were not significant in subjects with moderate VR. Extracellular HSPA1A did not differ and HSPD1 was undetectable. Drinkers of 40–60g/d and moderate VR or atherosclerotic disease presented the lowest concentrations of anti-Hsp70. The highest levels of serum anti-Hsp60 were shown in heavy male drinkers of >60g/d especially in subjects with moderate VR, and female drinkers of 40–60g/d.

Conclusions

The cardioprotective effect of 40–60g/d of alcohol consumption could be due in part, to increased intracellular HSPA1A, a potent anti-inflammatory protein. Excessive intake of alcohol increases antibodies anti-Hsp60, stimulating proinflammatory cytokines. This fact may explain the mortality from cardiovascular disease in heavy drinkers. The clinical application of antibody anti-Hsps quantification has been proposed in patients at risk in order to detect atherosclerotic disease.

Keywords:
Alcohol
Heat shock proteins
Atherosclerosis
Risk factors
Resumen
Fundamento y objetivos

Estudiar si el efecto cardioprotector del consumo regular de alcohol puede explicarse a través de las heat shock proteins (HSP, «proteínas de choque térmico»), dado su papel etiopatogénico en la ateroesclerosis.

Material y métodos

Estudio epidemiológico trasversal en 452 sujetos de 40-60 años de ambos sexos. Se realizó la historia clínica incluyendo frecuencia del consumo medio de alcohol y análisis bioquímicos, y se estatificó el grado de riesgo coronario según la Task Force. Se cuantificaron HSPA1A intracelular, HSPA1A y HSPD1 séricas y anti-Hsp70 y anti-Hsp60 por ELISA.

Resultados

Doscientos treinta y ocho (52,7%) sujetos eran abstemios o bebedores de<20g/d de alcohol; 123 (27,2%) bebían 20-40g/d, 66 (14,6%) 40-60g/d y 25>60g/d (5,5%). Doscientos treinta y nueve carecían de factores de riesgo vascular (RV) o tenían un RV<5%; 161 tenían RV moderado (10-20%) y 52 presentaban enfermedad ateroesclerótica instaurada. Los bebedores de 40-60g/d presentaron máximas concentraciones de HSPA1A intracelular, no significativas en RV moderado. HSPA1A sérica no presentó diferencias y HSPD1 fue indetectable. Los bebedores de 40-60g/d y RV moderado o enfermedad ateroesclerótica presentaron las menores concentraciones de anti-Hsp70. Los anti-Hsp60 fueron máximos en varones bebedores de>60g/d y en mujeres bebedoras de 40-60g/d, especialmente en RV moderado.

Conclusiones

El efecto cardioprotector del consumo de 40-60g/d de alcohol podría deberse, al menos en parte, al incremento de HSPA1A intracelular, potente proteína antiinflamatoria. El consumo excesivo regular de alcohol se asocia a un aumento de anticuerpos anti-Hsp60, estimulantes de citocinas proinflamatorias; ello podría explicar la mortalidad por enfermedad cardiovascular en estos pacientes. Se ha propuesto la aplicación clínica del seguimiento de anticuerpos anti-Hsp en pacientes en riesgo para detectar enfermedad ateroesclerótica.

Palabras clave:
Alcohol
Proteínas de choque térmico
Ateroesclerosis
Factores de riesgo

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos